Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Hilversum

67 clinical trials in Hilversum, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Hilversum at a glance
67
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

67 trials in Hilversum

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Janssen - Cilag International
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Hilversum

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on various cancer treatments, including prostate cancer, renal cell carcinoma, and lymphoma. Studies are evaluating innovative therapeutic combinations and targeted treatments.

  • Metastatic prostate cancer treatments
  • B-cell lymphoma therapies
  • Targeted cancer medications

Several trials are investigating novel drug combinations to improve patient outcomes and survival rates.

02 Cardiovascular Studies

Research focusing on cardiovascular disease prevention and treatment, including studies on stroke prevention and heart conditions. New therapeutic approaches are being tested for improved patient care.

  • Stroke prevention in atrial fibrillation
  • Cardiovascular risk reduction
  • Blood pressure management

Trials aim to evaluate new medications for better cardiovascular outcomes.

03 Nephrology Research

Studies examining treatments for chronic kidney disease and related conditions. Research focuses on novel therapeutic combinations and disease progression management.

  • CKD progression prevention
  • Hypertension management
  • Renal function preservation

Innovative approaches are being tested to improve outcomes for patients with kidney disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.